Hofseth Biocare Asa Stock Current Ratio
Hofseth Biocare ASA fundamentals help investors to digest information that contributes to Hofseth Biocare's financial success or failures. It also enables traders to predict the movement of Hofseth Stock. The fundamental analysis module provides a way to measure Hofseth Biocare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hofseth Biocare stock.
Hofseth |
Hofseth Biocare ASA Company Current Ratio Analysis
Hofseth Biocare's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Hofseth Biocare Current Ratio | 1.11 X |
Most of Hofseth Biocare's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hofseth Biocare ASA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Hofseth Biocare ASA has a Current Ratio of 1.11 times. This is 61.86% lower than that of the Healthcare sector and 84.14% lower than that of the Biotechnology industry. The current ratio for all Norway stocks is 48.61% higher than that of the company.
Hofseth Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hofseth Biocare's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hofseth Biocare could also be used in its relative valuation, which is a method of valuing Hofseth Biocare by comparing valuation metrics of similar companies.Hofseth Biocare is currently under evaluation in current ratio category among its peers.
Hofseth Fundamentals
| Return On Equity | -0.95 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (1.07) % | |||
| Current Valuation | 1.03 B | |||
| Shares Outstanding | 395.08 M | |||
| Shares Owned By Insiders | 52.50 % | |||
| Shares Owned By Institutions | 20.43 % | |||
| Price To Earning | (4.13) X | |||
| Price To Book | 5.19 X | |||
| Price To Sales | 8.29 X | |||
| Revenue | 87.62 M | |||
| Gross Profit | 28.51 M | |||
| EBITDA | (87.72 M) | |||
| Net Income | (126.46 M) | |||
| Cash And Equivalents | 36.52 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 123.31 M | |||
| Debt To Equity | 188.20 % | |||
| Current Ratio | 1.11 X | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (61.78 M) | |||
| Earnings Per Share | (0.38) X | |||
| Beta | 0.54 | |||
| Market Capitalization | 1.1 B | |||
| Total Asset | 415.97 M | |||
| Retained Earnings | (105 M) | |||
| Working Capital | (22 M) | |||
| Current Asset | 52 M | |||
| Current Liabilities | 74 M | |||
| Z Score | 4.8 | |||
| Net Asset | 415.97 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.